Country: United States
Language: English
Source: NLM (National Library of Medicine)
MODAFINIL (UNII: R3UK8X3U3D) (MODAFINIL - UNII:R3UK8X3U3D)
AvPAK
MODAFINIL
MODAFINIL 100 mg
ORAL
PRESCRIPTION DRUG
Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use In OSA, modafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with modafinil tablets for excessive sleepiness. Modafinil tablets are contraindicated in patients with known hypersensitivity to modafinil or armodafinil or its inactive ingredients [see Warnings and Precautions (5.1, 5.2, 5.3)] . Teratogenic Effects Pregnancy Category C There are no adequate and well-controlled studies of modafinil in pregnant
Modafinil Tablets USP, 100 mg are white to off-white, capsule-shaped, uncoated tablets, debossed with ‘41’ on one side and ‘J’ on the other side. NDC 50268-570-12 10 tablets per card, 2 cards per carton. Modafinil Tablets USP, 200 mg are white to off-white, capsule-shaped, uncoated tablets, debossed with ‘4’ & ‘2’ separated by score line on one side and ‘J’ on the other side. NDC 50268-571-12 10 tablets per card, 2 cards per carton. Dispensed in Unit Dose Package. For Institutional Use Only. Store at 20 o to 25 o C (68 o to 77 o F). [See USP Controlled Room Temperature.]
Abbreviated New Drug Application
MODAFINIL- MODAFINIL TABLET AvPAK ---------- MEDICATION GUIDE Modafinil Tablets, USP CIV (moe daf' i nil) Read this Medication Guide before you start taking modafinil tablets and each time you get a refill. There may be new information. This information does not take the place of talking with your doctor about your medical condition or treatment. What is the most important information I should know about modafinil tablets? Modafinil tablets may cause serious side effects including a serious rash or a serious allergic reaction that may affect parts of your body such as your liver or blood cells. Any of these may need to be treated in a hospital and may be life-threatening. Stop taking modafinil tablets and call your doctor right away or get emergency help if you have any of these symptoms: • skin rash, hives, sores in your mouth, or your skin blisters and peels • swelling of your face, eyes, lips, tongue, or throat • trouble swallowing or breathing • fever, shortness of breath, swelling of the legs, yellowing of the skin or whites of the eyes, or dark urine. If you have a severe rash with modafinil tablets, stopping the medicine may not keep the rash from becoming life-threatening or causing you to be permanently disabled or disfigured. Modafinil tablets are not approved for use in children for any medical condition. It is not known if modafinil tablets are safe or effective in children under 17 years of age. What are modafinil tablets? Modafinil tablets are a prescription medicine used to improve wakefulness in adults who are very sleepy due to one of the following diagnosed sleep disorders: • narcolepsy • obstructive sleep apnea (OSA). Modafinil tablets are used to treat excessive sleepiness, but not the obstruction or medical condition that is causing OSA. You should talk with your doctor about treatments for OSA before you start taking modafinil tablets and during treatment with modafinil tablets. Modafinil tablets do not take the place of treatments that your doctor has prescribed for OSA. It is i Read the complete document
MODAFINIL- MODAFINIL TABLET AVPAK ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION MODAFINIL TABLETS THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE MODAFINIL TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR MODAFINIL TABLETS. MODAFINIL TABLETS FOR ORAL USE, CIV INITIAL U.S. APPROVAL: 1998 INDICATIONS AND USAGE Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). (1) Limitations of Use In OSA, modafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. DOSAGE AND ADMINISTRATION The recommended dosage of modafinil tablets for each indication is as follows: Narcolepsy or OSA: 200 mg once a day in the morning. (2.1) SWD: 200 mg once a day, taken approximately one hour prior to start of the work shift. (2.2) Severe Hepatic Impairment: reduce dose to half the recommended dose. (2.3, 12.3) Geriatric Patients: consider lower dose. (2.4, 12.3) DOSAGE FORMS AND STRENGTHS Tablets: 100 mg and 200 mg. (3) CONTRAINDICATIONS Modafinil tablets are contraindicated in patients with known hypersensitivity to modafinil or armodafinil. (4) WARNINGS AND PRECAUTIONS Serious Rash, including Stevens-Johnson syndrome: Discontinue modafinil at the first sign of rash, unless the rash is clearly not drug-related. (5.1) Angioedema and Anaphylaxis Reactions: If suspected, discontinue modafinil. (5.2) Multi-organ Hypersensitivity Reactions: If suspected, discontinue modafinil. (5.3) Persistent Sleepiness: Assess patients frequently for degree of sleepiness and, if appropriate, advise patients to avoid driving or engaging in any other potentially dangerous activity. (5.4) Psychiatric Symptoms: Use caution in patients with a history of psychosis, depression, or mania. Consider discontinuing modafinil if psychiatric symptoms develop. (5.5) Known Cardiovascular Disease: Consider increased monitoring. (5.7) ADVERSE REACTIONS Read the complete document